1. Glucagonoma With Necrolytic Migratory Erythema: Metabolic Profile and Detection of Biallelic Inactivation of DAXX Gene
   Ai Tamura et al, 2018, The Journal of Clinical Endocrinology & Metabolism CrossRef
2. Benign-Appearing Glucagonoma Undergoing Malignant Transformation after a Prolonged Period
   Mohamed K.M. Shakir et al, 2020, Case Reports in Oncology CrossRef
3. A Case of Glucagonoma Showing Only Focally Positive Immunostaining for Glucagon
   Yusuke Nie et al, 2021, Nihon Gekakei Rengo Gakkaishi (Journal of Japanese College of Surgeons) CrossRef
4. Case of delayed diagnosis of necrolytic migratory erythema
   Wissal Abdelli et al, 2021, Clinical Case Reports CrossRef
5. Somatostatin analogs in the treatment of neuroendocrine tumors: current and emerging aspects
   Gherardo Mazziotti et al, 2017, Expert Opinion on Pharmacotherapy CrossRef
6. Hepatic Glucagonoma in a Post-bariatric Female Patient: A Case Report
   Sophia Garcia et al, 2023, Cureus CrossRef
7. Case report: Surgical treatment and literature review of a recurrent case of glucagonoma
   Zhipeng Liu et al, 2024, Frontiers in Oncology CrossRef
8. Necrolytic Migratory Erythema: A Forgotten Paraneoplastic Condition
   Catherine Tremblay et al, 2017, Journal of Cutaneous Medicine and Surgery CrossRef
9. Glucagonoma and Glucagonoma Syndrome: A Case Report with Review of Recent Advances in Management
   Ashraf Al-Faouri et al, 2016, Case Reports in Surgery CrossRef
10. Spleen-preserving distal pancreatectomy and lymphadenectomy for glucagonoma syndrome
    Xuefeng Cao et al, 2019, Medicine CrossRef
11. Manifestations of Glucagonoma Syndrome
    Mauricio Alvarez et al, 2020, AACE Clinical Case Reports CrossRef